China’s First COVID-19 Vaccine Patent Granted To CanSino Biologics

China's First COVID-19 Vaccine Patent Granted To CanSino Biologics
According to the Chinese Intellectual Property Administration, China's
vaccine maker CanSino Biologics Inc won the patent approval for its
COVID-19 vaccine candidate Ad5-nCoV, on Monday. According to
state-owned newspaper People's Daily, it is the first COVID-19 vaccine
patent granted by China. As per the patent document, […]

The post China's First COVID-19 Vaccine Patent Granted To CanSino
Biologics appeared first on BioTecNika .

https://www.biotecnika.org/2020/08/chinas-first-covid-19-vaccine-patent-granted-to-cansino-biologics/

Biotech News